Status:
COMPLETED
Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
Bayer
University Hospital, Bonn
Conditions:
Hemophilia A
Hemophilia B
Eligibility:
FEMALE
Brief Summary
This is a multi-center, international study designed to collect clinical, genetic and quality of life information on females with hemophilia, an inherited bleeding disorder. The study is designed to d...
Detailed Description
The study involves two questionnaires: one on the diagnosis, symptoms, complications and treatment of each participant to be completed by a staff member; the other is a questionnaire to be completed b...
Eligibility Criteria
Inclusion
- Females with severe (FVIII\<0.01u/ml) or moderate (FVIII 0.01≤0.05 u/ml) hemophilia A
- Females with severe (FIX\<0.01u/ml) or moderate (FIX 0.01≤0.05u/ml) hemophilia B
- Willingness to participate in the study.
Exclusion
- Subjects who do not meet the inclusion criteria with respect to gender or hemophilia severity.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00936312
Start Date
March 1 2008
End Date
August 1 2011
Last Update
December 10 2012
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medical College
New York, New York, United States, 10065
2
Princess Margaret Hospital for Children
Perth, Australia
3
University Clinic Bonn
Bonn, Germany
4
University Clinic Munich
Munich, Germany